This is a routine initial ownership filing for a new insider. No trading activity or change in beneficial ownership is indicated. Monitor future Form 4 filings for any subsequent transactions by Kuriakose.
MGNX drugs
MGNX drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $2.31entry
- T+1 · 12d ago −3.90%α +0.51% · $2.22
- T+5 · 6d ago +0.43%α +1.35% · $2.32
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Emil Kuriakose filed a Form 3 initial statement of beneficial ownership with MacroGenics Inc, reporting no securities beneficially owned. The filing also includes a limited power of attorney authorizing James Karrels, Jeffrey Peters, and Beth Smith to execute Section 16 filings on his behalf. This is a routine administrative filing with no material financial impact.
Key Facts
- Emil Kuriakose filed a Form 3 initial statement of beneficial ownership with MacroGenics Inc
- The filing reports 0 shares beneficially owned by Kuriakose
- A limited power of attorney was executed authorizing James Karrels, Jeffrey Peters, and Beth Smith to handle Section 16 filings
- The Form 3 was signed by Beth A. Smith as attorney-in-fact on 2026-11-03
Financial Impact
No financial impact; no securities reported owned
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001892413-26-000013 |
| Document: 0001892413-26-000013-index-headers.html | 0001892413-26-000013 |
| Document: 0001892413-26-000013-index.html | 0001892413-26-000013 |
| Document: 0001892413-26-000013.txt | 0001892413-26-000013 |
Track record
21 reports on MGNX
4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +130.41% at T+60 after the Feb 28, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $2.22 Now $2.17 −2.25% settles Feb 12
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $2.31 Now $2.17 −6.06% settles Feb 12
- Nov 12, 20264d ago Press Release Bearish 5/10 Entry $2.20 Now $2.17 +1.36% settles Feb 11
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $2.31 Now $2.17 −6.06% settles Feb 2
- Nov 3, 202613d ago 3 Neutral 1/10 Viewing Entry $2.31 Now $2.17 −6.06% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $2.31 Now $2.17 −6.06% settles Feb 2
- Oct 26, 202621d ago Press Release Bullish 6/10 Entry $2.19 Now $2.17 −0.91% settles Jan 22
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $2.19 Now $2.17 −0.91% settles Jan 22
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $2.25 Now $2.17 −3.56% settles Jan 21
- Oct 15, 20264w ago Press Release Neutral 3/10 Entry $3.25 Now $2.17 −33.23% settles Jan 13
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers